If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases
✍ Scribed by Anna Marsk; Charlotta Grunewald; Sissel Saltvedt; Lil Valentin; Harald Almström
- Book ID
- 111732900
- Publisher
- Informa plc
- Year
- 2006
- Tongue
- English
- Weight
- 73 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0001-6349
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In the ®rst trimester of pregnancy the biochemical markers free b-hCG and pregnancy associated plasma protein-A (PAPP-A) are used for the prenatal screening of trisomy 21, either alone or in combination with nuchal translucency (NT) thickness. In this study, I have analysed the distribution of these
In a population of 1467 women attending the 'G. Gaslini' Institute for antenatal care, we evaluated first-trimester risk screening for Down syndrome using the 'combined test' based on ultrasound measurement of nuchal translucency (NT), maternal serum pregnancy-associated plasma protein A (PAPP-A) an